InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: Paullee post# 164

Wednesday, 05/01/2019 10:09:30 AM

Wednesday, May 01, 2019 10:09:30 AM

Post# of 1145
20% of net sales, plus other fees.. the C1 platform can become a formidable revenue source for Dyadic. Imagine similar deals on dozens of drugs and vaccines, all the while they retain IP. Talk about multiple shots on goal .. in their case it's literally hundreds of shots of goal, all without them having to pay for expensive trials. This is a multi-billion dollar platform in the making. Patience here will be generously rewarded, IMO. Market cap today just $90MM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DYAI News